The role of S100 proteins has been widely examined in breast cancer, lung cancer, and melanoma, but pathologic S100 signalling could also be observed in additional cancer types, such as ovarian, colorectal, and pancreatic cancer. The gene discussed is S100A1; the disease is breast carcinoma.